Go Pro
Yaron Werber

Yaron Werber Analyst Performance

Managing Director, Senior Biotechnology Analyst at TD Cowen

Yaron Werber is a stock analyst at TD Cowen in the healthcare sector, covering 22 publicly traded companies. Over the past year, Yaron Werber has issued 20 stock ratings, including buy and hold recommendations. While full access to Yaron Werber's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yaron Werber's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
43 Last 11 Years
Buy Recommendations
62.79% 27 Buy Ratings
Companies Covered
22 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy62.8%27 ratings
Hold37.2%16 ratings
Sell0.0%0 ratings

Out of 43 total stock ratings issued by Yaron Werber at TD Cowen, the majority (62.8%) have been Buy recommendations, followed by 37.2% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
22 companies

Yaron Werber, an analyst at TD Cowen, currently covers 22 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
22 companies
100.0%

Yaron Werber of TD Cowen specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
21 companies
95.5%
PHARMACEUTICALS
1 company
4.5%

Yaron Werber's Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
8/14/2026Boost Price Target$246.23$341.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
8/12/2026Lower Price Target$20.86$24.00Hold
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
8/6/2026Reiterated Rating$35.12Buy
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
8/6/2026Boost Price Target$329.22$454.00Buy
Amgen Inc. stock logo
AMGN
Amgen
8/5/2026Boost Price Target$406.27$452.00Buy
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
7/22/2026Upgrade$28.36$43.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
6/15/2026Reiterated Rating$73.49$108.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
5/21/2026Boost Price Target$32.51$41.00Buy
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
5/15/2026Downgrade$0.96Hold
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
5/13/2026Boost Price Target$28.27$29.00Hold
Exelixis, Inc. stock logo
EXEL
Exelixis
5/6/2026Boost Price Target$46.04$55.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
4/23/2026Lower Price Target$74.61$108.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/11/2026Lower Price Target$89.96$94.00Hold
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
1/22/2026Reiterated Rating$20.76$21.00Hold
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
1/20/2026Downgrade$57.52Hold
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
12/17/2025Initiated Coverage$15.35Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
11/5/2025Lower Price Target$31.31$75.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
11/5/2025Boost Price Target$40.31$51.00Buy
argenex SE stock logo
ARGX
argenex
10/31/2025Boost Price Target$809.94$1,146.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
10/30/2025Boost Price Target$74.24$99.00Buy
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
4/24/2025Reiterated Rating$257.36$334.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
1/21/2025Initiated Coverage$15.60Buy